ID

33152

Beschreibung

Exeantide in Type 2 Diabetes on Insulin; ODM derived from: https://clinicaltrials.gov/show/NCT01154933

Link

https://clinicaltrials.gov/show/NCT01154933

Stichworte

  1. 29.11.18 29.11.18 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

29. November 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Type 2 Diabetes NCT01154933

Eligibility Type 2 Diabetes NCT01154933

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
males or females 20-75 years of age inclusive.
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
type 2 diabetes
Beschreibung

Diabetes Mellitus, Non-Insulin-Dependent

Datentyp

boolean

Alias
UMLS CUI [1]
C0011860
on insulin therapy
Beschreibung

Insulin regime

Datentyp

boolean

Alias
UMLS CUI [1]
C0557978
hba1c ≥7.5% and ≤ 9%
Beschreibung

Hemoglobin A1c measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0474680
bmi ≥ 30 kg/m2
Beschreibung

Body mass index

Datentyp

boolean

Alias
UMLS CUI [1]
C1305855
subjects on statins, ace inhibitors, metformin, thiazolidinediones and antioxidants will be allowed as long as they are on stable doses of these compounds and the dosage in not changed during the study.
Beschreibung

Statins Dose Stable | Angiotensin-Converting Enzyme Inhibitors Dose Stable | Metformin Dose Stable | Thiazolidinediones Dose Stable | Antioxidants Dose Stable | Pharmaceutical Preparations Dose unchanged

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0360714
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0205360
UMLS CUI [2,1]
C0003015
UMLS CUI [2,2]
C0178602
UMLS CUI [2,3]
C0205360
UMLS CUI [3,1]
C0025598
UMLS CUI [3,2]
C0178602
UMLS CUI [3,3]
C0205360
UMLS CUI [4,1]
C1257987
UMLS CUI [4,2]
C0178602
UMLS CUI [4,3]
C0205360
UMLS CUI [5,1]
C0003402
UMLS CUI [5,2]
C0178602
UMLS CUI [5,3]
C0205360
UMLS CUI [6,1]
C0013227
UMLS CUI [6,2]
C0178602
UMLS CUI [6,3]
C0442739
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
coronary event or procedure (myocardial infarction, unstable angina, coronary artery bypass, surgery or coronary angioplasty) in the previous four weeks
Beschreibung

Event Coronary | Procedures on Coronary Arteries | Myocardial Infarction | Angina, Unstable | Coronary Artery Bypass Surgery | Operative Surgical Procedures | Coronary angioplasty

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0441471
UMLS CUI [1,2]
C1522318
UMLS CUI [2]
C0869781
UMLS CUI [3]
C0027051
UMLS CUI [4]
C0002965
UMLS CUI [5]
C0010055
UMLS CUI [6]
C0543467
UMLS CUI [7]
C0190211
pregnancy
Beschreibung

Pregnancy

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
hepatic disease (abnormal lft's)
Beschreibung

Liver diseases | Liver function tests abnormal

Datentyp

boolean

Alias
UMLS CUI [1]
C0023895
UMLS CUI [2]
C0151766
use of dpp4 inhibitors.
Beschreibung

Dipeptidyl-Peptidase IV Inhibitors

Datentyp

boolean

Alias
UMLS CUI [1]
C1827106
renal impairment (serum creatinine > 1.5)
Beschreibung

Renal Insufficiency | Creatinine measurement, serum

Datentyp

boolean

Alias
UMLS CUI [1]
C1565489
UMLS CUI [2]
C0201976
participation in any other concurrent clinical trial
Beschreibung

Study Subject Participation Status

Datentyp

boolean

Alias
UMLS CUI [1]
C2348568
any other life-threatening, non-cardiac disease
Beschreibung

Life threatening illness | Exception Heart Disease

Datentyp

boolean

Alias
UMLS CUI [1]
C3846017
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0018799
uncontrolled hypertension (bp > 160/100 mm of hg)
Beschreibung

Uncontrolled hypertension | Blood pressure determination

Datentyp

boolean

Alias
UMLS CUI [1]
C1868885
UMLS CUI [2]
C0005824
congestive heart failure.
Beschreibung

Congestive heart failure

Datentyp

boolean

Alias
UMLS CUI [1]
C0018802
use of an investigational agent or therapeutic regimen within 30 days of study
Beschreibung

Investigational New Drugs | Therapies, Investigational

Datentyp

boolean

Alias
UMLS CUI [1]
C0013230
UMLS CUI [2]
C0949266

Ähnliche Modelle

Eligibility Type 2 Diabetes NCT01154933

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
males or females 20-75 years of age inclusive.
boolean
C0001779 (UMLS CUI [1])
Diabetes Mellitus, Non-Insulin-Dependent
Item
type 2 diabetes
boolean
C0011860 (UMLS CUI [1])
Insulin regime
Item
on insulin therapy
boolean
C0557978 (UMLS CUI [1])
Hemoglobin A1c measurement
Item
hba1c ≥7.5% and ≤ 9%
boolean
C0474680 (UMLS CUI [1])
Body mass index
Item
bmi ≥ 30 kg/m2
boolean
C1305855 (UMLS CUI [1])
Statins Dose Stable | Angiotensin-Converting Enzyme Inhibitors Dose Stable | Metformin Dose Stable | Thiazolidinediones Dose Stable | Antioxidants Dose Stable | Pharmaceutical Preparations Dose unchanged
Item
subjects on statins, ace inhibitors, metformin, thiazolidinediones and antioxidants will be allowed as long as they are on stable doses of these compounds and the dosage in not changed during the study.
boolean
C0360714 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0003015 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0205360 (UMLS CUI [2,3])
C0025598 (UMLS CUI [3,1])
C0178602 (UMLS CUI [3,2])
C0205360 (UMLS CUI [3,3])
C1257987 (UMLS CUI [4,1])
C0178602 (UMLS CUI [4,2])
C0205360 (UMLS CUI [4,3])
C0003402 (UMLS CUI [5,1])
C0178602 (UMLS CUI [5,2])
C0205360 (UMLS CUI [5,3])
C0013227 (UMLS CUI [6,1])
C0178602 (UMLS CUI [6,2])
C0442739 (UMLS CUI [6,3])
Item Group
C0680251 (UMLS CUI)
Event Coronary | Procedures on Coronary Arteries | Myocardial Infarction | Angina, Unstable | Coronary Artery Bypass Surgery | Operative Surgical Procedures | Coronary angioplasty
Item
coronary event or procedure (myocardial infarction, unstable angina, coronary artery bypass, surgery or coronary angioplasty) in the previous four weeks
boolean
C0441471 (UMLS CUI [1,1])
C1522318 (UMLS CUI [1,2])
C0869781 (UMLS CUI [2])
C0027051 (UMLS CUI [3])
C0002965 (UMLS CUI [4])
C0010055 (UMLS CUI [5])
C0543467 (UMLS CUI [6])
C0190211 (UMLS CUI [7])
Pregnancy
Item
pregnancy
boolean
C0032961 (UMLS CUI [1])
Liver diseases | Liver function tests abnormal
Item
hepatic disease (abnormal lft's)
boolean
C0023895 (UMLS CUI [1])
C0151766 (UMLS CUI [2])
Dipeptidyl-Peptidase IV Inhibitors
Item
use of dpp4 inhibitors.
boolean
C1827106 (UMLS CUI [1])
Renal Insufficiency | Creatinine measurement, serum
Item
renal impairment (serum creatinine > 1.5)
boolean
C1565489 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
Study Subject Participation Status
Item
participation in any other concurrent clinical trial
boolean
C2348568 (UMLS CUI [1])
Life threatening illness | Exception Heart Disease
Item
any other life-threatening, non-cardiac disease
boolean
C3846017 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0018799 (UMLS CUI [2,2])
Uncontrolled hypertension | Blood pressure determination
Item
uncontrolled hypertension (bp > 160/100 mm of hg)
boolean
C1868885 (UMLS CUI [1])
C0005824 (UMLS CUI [2])
Congestive heart failure
Item
congestive heart failure.
boolean
C0018802 (UMLS CUI [1])
Investigational New Drugs | Therapies, Investigational
Item
use of an investigational agent or therapeutic regimen within 30 days of study
boolean
C0013230 (UMLS CUI [1])
C0949266 (UMLS CUI [2])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video